Company intelligence / Profile preview
NovaRock Biotherapeutics
Ewing, New Jersey, United Statesnovarockbio.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Phase 1
01
Overview
NovaRock has multiple clinical-stage programs focused on novel monoclonal and bispecific antibodies targeting cancer and autoimmune diseases. Lead assets NBL‑015, NBL‑020, NBL‑012, and NBL‑028 are in Phase I trials for various solid tumors or immune-mediated conditions. The company has established strategic partnerships to accelerate development globally.
- Therapeutic areas
- GastroenterologyOncologyDermatology
- Modalities
- Monoclonal antibodyBispecific antibodyAntibody-drug conjugateBispecific T-cell engager (BiTE)
- Industry
- Biotech
02
Drug pipeline
19 assets18 more assets in the full pipeline.
Request access →03
Partnerships
Flame Biosciences – exclusive rights to develop/commercialize NBL‐015 outside Greater ChinaShanghai JMT-Bio Technology/CSPC Pharmaceutical Group – co-development of IL‐23p19 neutralizing mAb program for psoriasis/IBD
Beyond the preview
Go deeper on NovaRock Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NovaRock Biotherapeutics.